Hepatectomy + XELOX for Liver Metastasis of Colorectal Cancer

Trial Profile

Hepatectomy + XELOX for Liver Metastasis of Colorectal Cancer

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 02 Jun 2017

At a glance

  • Drugs Capecitabine (Primary) ; Oxaliplatin
  • Indications Colorectal cancer; Liver metastases
  • Focus Therapeutic Use
  • Acronyms adjXELOX
  • Most Recent Events

    • 02 Jun 2017 Primary endpoint (Treatment completion rate) has been met as per the results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
    • 02 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
    • 24 Oct 2014 Chugai Pharmaceutical plans to file for regulatory submission in 2014 based on the results of this study.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top